Antag Therapeutics
Operator of a biotechnology company intended to focus on developing metabolic and anti-obesity therapeutic drugs. The company specializes in the creation of peptide-based gastric inhibitory polypeptid...
Valuation
$0
Share Price
N/A
Total Raised
$93.1M
Last Round
N/A